Abstract: Three new physalin steroids, physalin III (1), physalin IV (2), 3-O-methylphysalin X (3), together with five known physalins (4-8) were isolated from the 80% EtOH extract of calyces of Physalis alkekengi var. franchetii. The structures of the new compounds were revealed through 1D and 2D NMR and mass spectroscopic studies.
Introduction
The genus of Physalis (Solanaceae), including about 120 species, is widely distributed throughout South and North America, which also includes five species, and two variations which also can be found in China 1 . The plant Physalis alkekengi var. franchetii, is used in traditional Chinese medicine 2 , and is chiefly used for the treatment and prevention of tumors, leishmaniasis, sore throat, cough, eczema, hepatitis and urinary problems 3 . The chemical constituents of P. alkekengi var. franchetii are mainly composed of alkaloids, flavonoids, sterols, fatty acids, amino acids, and steroids 4 . Physalins, as one of the characteristic constituents from P. alkekengi var. franchetii, is a type of steroids with 16,24-cyclo-13,14-seco-ergostane skeleton which has been established by X-ray crystallographic analysis [5] [6] [7] . Neophysalins, are another characteristic structure, and are transformed from physalins through an acid-induced benzilic acid-type rearrangement reaction 8 . , anti-inflammatory 13, 14 , immunomodulatory 15 , cytotoxic 16 , and trypanocidal 17, 18 effects.
In this study, five physalins (1, 2, 4-6) and three neophysalins (3, 7, 8) were isolated from P. alkekengi var. franchetii, three of which (1-3) were new. Their chemical structures and their elucidation are described herein.
Results and Discussion
Compound 1 was obtained as a white powder. The relative configurations of H-8 and Me-28 in the physalin skeleton were established to be β-oriented by X-ray. 20, 21 Thus, the NOE correlations (Figure 1 ) of H-4/H-6, H-6/H-7, H-7/H-8β, and H-27/Me-28 established the relative configuration of OH-4 and OH-7 to be α-oriented and Me-27 to be β-oriented. Hence, the structure of compound 1 was identified to be physalin III (1).
Compound 2 was obtained as a colorless needle crystal. The molecular formula of 2 was determined to be C 28 H 32 O 12 on the basis of HREIMS (m/z 560.1854, [M] + ; calcd 560.1894) and NMR data ( Table 1 ). The NMR data of 2 were similar to those of physalin Z 22 , and the differences between them were two of the double-bond carbon signals in physalin Z were replaced by two oxygenated methine signals in 2 located at C-6 and C-7, which were deduced by (Figure 2 ) of H-6/H-7 and H-7/H-8β revealed that OH-C(6) and OH-C(7) were α-oriented. So the structure of compound 2 was deduced and named as physalin IV (2).
Compound 3 was obtained as an amorphous yellow powder. The molecular formula of 3 was determined as C 29 H 32 O 10 using HREIMS and NMR data ( Table 1) . These NMR data of 3 were similar to those of physalin X 23 , except the presence of an additional methoxyl group. Comparing with physalin X, the chemical shift of C-3 (δ C 76.7) at down field and the HMBC correlation (Figure 3) of OMe (δ H 3.27) with C-3 in 3 indicated a methoxyl group at C-3. The relative configuration of Me-19 and H-16 in physalin skeleton were established to be β-oriented by X-ray. 20, 21 So the relative configuration of 3-OMe could be determined as α-oriented by the NOE correlations of Me-19/H-3 and H-16/H-3. Hence, the structure of compound 3 was identified to be 3-O-methylphysalin X (3). The structures of five known steroidal compounds, physalin Z (4) 22 , physalin C (5) 24 , physalin I (6) 25 , physalin P (7) 26 , 25,27-dihydro-4,7-dedehydro-7-deoxyneophysalin A (8) 27 , were elucidated in comparison to their spectroscopic data with those reported in the literature.
Experimental Section
General Experimental Procedures. 1) . Then, the CHCl 3 -MeOH (100:1) portion (80 g) was chromatographed on a silica gel column using a gradient of CHCl 3 -CH 3 OH (100:0 to 0:100), which yielded five fractions (1-5). Fraction 2 was successively subjected to RP-18, Sephadex LH-20 and silica gel to derive subfractions I-IV. Subfraction II was further separated over silica gel with CHCl 3 -CH 3 OH (120:1) to yield compound 3 (5 mg), 6 (4 mg), 7 (10 mg) and 8 (3 mg). Subfraction III was subjected to semipreparative HPLC (CH 3 CN-H 2 O, 50:50) to produce 4 (1 mg) and 5 (1 mg). Fraction 3 was successively subjected to RP-18, Sephadex LH-20 and separated over silica gel with CHCl 3 -CH 3 OH (80:1) to yield 1 (2 mg) and 2 (6 mg). 
Electronic Supplementary Material
Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s13659-013-0021-z and is accessible for authorized users. Key HMBC (H→C) and ROESY(H H) correlations of compound 3
